Driving CAR-T therapy safety and sustainability for the road ahead

Q&A with Abby McDonald, PhD, Solutions Development Supervisor

An opportunity to impact the future of medicine

As told by Leah, Be The Match BioTherapies® allogeneic donor

The challenge of multiple audits and redundant training

A case study from UCLA Health

Industry stakeholders propose unified CAR T toxicity grading scale

CIBMTR Cellular Therapy Registry recommended to meet outcomes data reporting requirements

Advancements in Cell Therapy: 2018 Year-In-Review

Reimbursement uncertainties hinder patient access to CAR-T therapies

Cell Lines In-the-News: August 2018

Advances in immunotherapy for hematologic diseases

Cell Therapy in 2018: Mid-year review